Diet as a therapy for irritable bowel syndrome: progress at last.
M. Simrén
DOI: https://doi.org/10.1053/j.gastro.2013.11.027
IF: 29.4
Gastroenterology
Abstract:ostprandial worsening of symptoms, as well as Padverse reactions to one or more foods are common in patients with irritable bowel syndrome (IBS), and selfreported food intolerance in IBS is associated with a high symptom burden and reduced quality of life. In line with this, approximately two thirds of IBS patients exclude food items from their diet to improve symptoms. Despite this, there is no evidence suggesting inadequate nutrient intake in the majority of patients with IBS. For patients, identifying the food item/s they do not tolerate is often central when consulting for their symptoms, and in general guidelines for management of IBS, dietary advice is proposed to be of major importance. However, there are currently no available evidence-based guidelines for dietetic practice in IBS, as very few randomized, controlled trials exist on dietary treatment of IBS patients. Instead, the current recommendations are primarily based on studies assessing physiologic function in relation to dietary components, and to a lesser degree on research based on randomized, controlled trials examining the role of dietary components in the therapeutic management of IBS patients. Therefore, the article by Halmos et al published in this issue of Gastroenterology is a welcome addition to the existing literature. In a randomized, controlled trial, they demonstrate that reducing the intake of poorly absorbed short-chain carbohydrates, or fermentable oligosaccharides, disaccharides, monosaccharides and polyols (FODMAPs), substantially improves the severity of the key symptoms of IBS. The hypothesis that reducing intake of FODMAPs can improve gastrointestinal (GI) symptoms stems from the clinical observation that a proportion of patients with IBS tolerate intake of certain short-chain carbohydrates poorly. Moreover, these carbohydrates can be incompletely absorbed in the small intestine due to absent hydrolyzation (eg, lactose maldigestion, and nondigestible oligosaccharides), dependence on simultaneous intake of glucose for adequate absorption (fructose), or passive diffusion (certain monosaccharides and polyols). Therefore, the absorption of short-chain carbohydrates in the small intestine varies depending on different factors such as presence/absence of enzymes to digest disaccharides (eg, lactase), small intestinal transit time, dose of the carbohydrate, meal composition, and also on the presence of mucosal disease. If a proportion of the FODMAPs pass unabsorbed through the small intestine, this increases intestinal luminal water content through osmosis, and increases gas production via fermentation by gut bacteria, leading to intestinal distension, which may cause symptoms in susceptible individuals. Moreover,